BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30211722)

  • 41. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
    Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
    J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
    Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
    HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database.
    Zhou J; Paton NI; Ditangco R
    Int J STD AIDS; 2007 Jul; 18(7):446-52. PubMed ID: 17623500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early mortality in a cohort of people living with HIV in Rio de Janeiro, Brazil, 2004-2015: a persisting problem.
    Leite PHAC; Coelho LE; Cardoso SW; Moreira RI; Veloso VG; Grinsztejn B; Luz PM
    BMC Infect Dis; 2022 May; 22(1):475. PubMed ID: 35581552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
    Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
    JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
    Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
    Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate Cancer Screening and Incidence among Aging Persons Living with HIV.
    Leapman MS; Stone K; Wadia R; Park LS; Gibert CL; Goetz MB; Bedimo R; Rodriguez-Barradas M; Shebl F; Justice AC; Brown ST; Crothers K; Sigel KM
    J Urol; 2022 Feb; 207(2):324-332. PubMed ID: 34555924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia.
    Chow JY; Alsan M; Armstrong W; del Rio C; Marconi VC
    AIDS Care; 2015; 27(7):844-8. PubMed ID: 25660100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.
    Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients.
    Chaussade H; Le Marec F; Coureau G; Leleux O; Neau D; Lazaro E; Amadeo B; Duffau P; Ferrand H; Courtault C; Foucan AS; Wittkop L; Bonnet F
    AIDS; 2022 Apr; 36(5):665-673. PubMed ID: 34923517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
    Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AIDS-Defining Illnesses at Initial Diagnosis of HIV in a Large Guatemalan Cohort.
    Reinhardt SW; Spec A; Meléndez J; Alonzo Cordon A; Ross I; Powderly WG; Mejia Villatoro C
    Open Forum Infect Dis; 2017; 4(4):ofx249. PubMed ID: 29308405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.
    Althoff KN; McGinnis KA; Wyatt CM; Freiberg MS; Gilbert C; Oursler KK; Rimland D; Rodriguez-Barradas MC; Dubrow R; Park LS; Skanderson M; Shiels MS; Gange SJ; Gebo KA; Justice AC;
    Clin Infect Dis; 2015 Feb; 60(4):627-38. PubMed ID: 25362204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal Lung Cancer Screening Criteria Among Persons Living With HIV.
    Sellers SA; Edmonds A; Ramirez C; Cribbs SK; Ofotokun I; Huang L; Morris A; Mccormack MC; Kunisaki KM; D'souza G; Rivera MP; Drummond MB; Adimora AA
    J Acquir Immune Defic Syndr; 2022 Jun; 90(2):184-192. PubMed ID: 35125470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
    Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
    Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respiratory symptoms and chronic bronchitis in people with and without HIV infection.
    Sabin CA; Kunisaki KM; Bagkeris E; Post FA; Sachikonye M; Boffito M; Anderson J; Mallon P; Williams I; Vera JH; Johnson M; Babalis D; Winston A
    HIV Med; 2021 Jan; 22(1):11-21. PubMed ID: 32892488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
    Grinsztejn B; Veloso VG; Pilotto JH; Campos DP; Keruly JC; Moore RD
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):515-20. PubMed ID: 17558332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.